生物活性 | |||
---|---|---|---|
描述 | SW157765 selectively inhibits the non-canonical glucose transporter GLUT8 (SLC2A8). NSCLC cells harboring KRAS/KEAP1 double mutations are particularly vulnerable to SW157765, due to its impact on metabolic and xenobiotic gene regulatory programs modulated by both KRAS and NRF2 [1][2]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
3.02mL 0.60mL 0.30mL |
15.09mL 3.02mL 1.51mL |
30.18mL 6.04mL 3.02mL |
参考文献 |
---|